Related Experiment Video
Updated: Apr 24, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
MDM2 overexpression, activation of signaling networks, and cell proliferation
Swati Palit Deb1, Shilpa Singh, Sumitra Deb
1Department of Biochemistry and Molecular Biology, and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, 23298, USA, spdeb@vcu.edu.
Abstract:
Frequent overexpression of MDM2 in human cancers suggests that the protein confers a survival advantage to cancer cells. However, overexpression of MDM2 in normal cells seems to restrict cell proliferation. This review discusses the cell growth regulatory functions of MDM2 in normal and genetically defective cells to assess how cancer cells evade the growth-restricting consequence of MDM2 overexpression. Similar to oncoproteins that induce a DNA damage response and oncogene induced senescence in non-transformed cells, MDM2 induces G1-arrest and intra-S phase checkpoint responses that control untimely DNA replication in the face of genetic challenges.
Insights
MDM2 overexpression aids cancer cell survival but restricts normal cell growth. Cancer cells evade this restriction, while MDM2 induces cell cycle arrest in normal cells to prevent DNA replication errors.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Cycle Regulation
Background:
- MDM2 is frequently overexpressed in human cancers, suggesting a role in cancer cell survival.
- Conversely, MDM2 overexpression in normal cells appears to inhibit proliferation.
Purpose of the Study:
- To review the cell growth regulatory functions of MDM2 in normal and genetically defective cells.
- To understand how cancer cells evade the growth-restrictive effects of MDM2 overexpression.
Main Methods:
- Literature review of MDM2 functions in normal and cancer cells.
- Analysis of MDM2's role in cell cycle checkpoints and DNA replication control.
Main Results:
- MDM2 acts as a cell growth regulator, inducing G1-arrest and intra-S phase checkpoints.
- These responses in normal cells prevent DNA replication under genetic stress.
Conclusions:
- Cancer cells develop mechanisms to bypass MDM2-induced growth restriction.
- Understanding MDM2's dual role is crucial for cancer therapy development.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Mitogens and the Cell Cycle

